SCHEMBL20152777

SCHEMBL20152777

CC1(C)c2ccccc2-c2c3c1cccc3cc1c3ccc4ccccc4c3n(-c3cccc4ccccc34)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CYP1A2 P05177 2/20 0.33
▸ FYN P06241 2/20 0.33
▸ ACHE P22303 2/20 0.33
▸ AHR P35869 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LCK P06239 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ POLB P06746 1/20 0.32
▸ ERBB2 P04626 1/20 0.31
▸ MAOA P21397 1/20 0.31
▸ GSK3A P49840 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ CES1 P23141 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20152773 0.92 MAPT (0.33) MAPTMEN1KMT2AKDM4EMAPK1
SCHEMBL20152766 0.89 MAPT (0.33) MAPTMEN1KMT2AKDM4EMAPK1
SCHEMBL20152607 0.89 MEN1 (0.37) MAPTMEN1KMT2AKDM4EMAPK1
SCHEMBL20152817 0.88 MEN1 (0.36) MAPTMEN1KMT2AKDM4EMAPK1
SCHEMBL20152772 0.87 CYP1A2 (0.32) MAPTCYP1A2FYNACHEAHR
SCHEMBL20152716 0.87 MEN1 (0.36) MAPTMEN1KMT2AKDM4EMAPK1
SCHEMBL20152767 0.86 ALDH1A1 (0.32) MAPTCYP1A2FYNACHEAHR
SCHEMBL20152768 0.85 PDE6D (0.35) MAPTMEN1KMT2AKDM4ECYP1A2
SCHEMBL20152789 0.85 ALDH1A1 (0.31) MAPTMEN1KMT2AKDM4ECYP1A2
SCHEMBL20152775 0.85 KDM4E (0.31) MAPTKDM4ECYP1A2FYNACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580996-B2 Polycyclic compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2020-03-03 — — US disclosed
US-20180138421-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-17 — — US disclosed
US-20180138421-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180138421-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CRY2, NR2E3, CRY1 MAPT 530/4885MEN1 396/4885KMT2A 145/4885
US-10580996-B2 Polycyclic compound and organic light-emitting element comprising same CRY2, NR2E3, CRY1 MAPT 530/4885MEN1 396/4885KMT2A 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback